Erenumab for Migraine Treatment - First Real World Data from Germany

被引：0
|
作者：
Naegel, Steffen [1 ,2 ]
Scheffler, Armin [1 ]
Wurthmann, Sebastian F. [1 ]
Holle, Dagny [1 ]
机构：
[1] Univ Hosp Essen, Dept Neurol, Essen, Germany
[2] Univ Hosp Halle, Dept Neurol, Halle, Germany
来源：
CEPHALALGIA | 2019年 / 39卷 / 1_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
IHC-LB-078
引用
收藏
页码：409 / 409
页数：1
相关论文
共 50 条
  • [21] Efficacy of Galcanezumab for the treatment of migraine in Korea: the first real-world data from an Asian country
    Kwon, S.
    Gil, Y. E.
    Lee, M. J.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 78 - 79
  • [22] Efficacy of Galcanezumab for the treatment of migraine in Korea: the first real-world data from an Asian country
    Kwon, S.
    Gil, Y. E.
    Lee, M. J.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 52 - 52
  • [23] Erenumab in the treatment of migraine
    Jain, Sameer
    Yuan, Hsiangkuo
    Spare, Nicole
    Silberstein, Stephen D.
    PAIN MANAGEMENT, 2018, 8 (06) : 415 - 426
  • [24] Treatment of chronic migraine with Erenumab alone or as an add on therapy; a real world prospective observational study
    Boudreau, Guy P.
    Catherine, Demers
    CEPHALALGIA, 2019, 39 (1_SUPPL) : 367 - 367
  • [25] Erenumab in highly therapy-refractory migraine patients: First German real-world evidence
    Armin Scheffler
    Olga Messel
    Sebastian Wurthmann
    Michael Nsaka
    Christoph Kleinschnitz
    Martin Glas
    Steffen Naegel
    Dagny Holle
    The Journal of Headache and Pain, 2020, 21
  • [26] Chronic migraine evolution after 3 months from erenumab suspension: real-world-evidence-life data
    Guerzoni, Simona
    Baraldi, Carlo
    Pensato, Umberto
    Favoni, Valentina
    Lo Castro, Flavia
    Cainazzo, Maria Michela
    Cevoli, Sabina
    Pani, Luca
    NEUROLOGICAL SCIENCES, 2022, 43 (06) : 3823 - 3830
  • [27] Two Year Real World Prospective Quality of Life Data in Treatment Refractory Chronic Migraine Patients Treated with Erenumab in Ireland
    Troy, E.
    Shrukalla, A. A.
    Buture, A.
    Conaty, K.
    Macken, E.
    Lonergan, R.
    Melling, J.
    Long, N.
    Shaikh, E.
    Tomkins, E.
    Ruttledge, M.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 121 - 122
  • [28] Chronic migraine evolution after 3 months from erenumab suspension: real-world-evidence-life data
    Simona Guerzoni
    Carlo Baraldi
    Umberto Pensato
    Valentina Favoni
    Flavia Lo Castro
    Maria Michela Cainazzo
    Sabina Cevoli
    Luca Pani
    Neurological Sciences, 2022, 43 : 3823 - 3830
  • [29] Erenumab in highly therapy-refractory migraine patients: First German real-world evidence
    Scheffler, Armin
    Messel, Olga
    Wurthmann, Sebastian
    Nsaka, Michael
    Kleinschnitz, Christoph
    Glas, Martin
    Naegel, Steffen
    Holle, Dagny
    JOURNAL OF HEADACHE AND PAIN, 2020, 21 (01):
  • [30] Two Year Real World Prospective Quality of Life Data in Treatment Refractory Chronic Migraine Patients Treated with Erenumab in Ireland
    Troy, E.
    Shrukalla, A. A.
    Buture, A.
    Conaty, K.
    Macken, E.
    Lonergan, R.
    Melling, J.
    Long, N.
    Shaikh, E.
    Tomkins, E.
    Ruttledge, M.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 181 - 181
12345